<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT924-13141</title>
	</head>
	<body>
		<main>
			<p>921016 FT  16 OCT 92 / International Company News: Earnings at Genentech decline 43% to Dollars 7.7m GENENTECH, the California-based biotechnology company that was acquired by Roche Holdings of Switzerland in 1990, yesterday said its third-quarter net earnings declined by 43 per cent to Dollars 7.7m. The drop was due primarily to continued heavy investment in research and development, the company said. On a per-share basis, Genentech's third-quarter earnings were seven cents, compared with 12 cents a year ago. Third-quarter revenues were up 2 per cent, at Dollars 137.3m. Genentech's R&amp;D spending in the quarter was Dollars 69.6m, up from Dollars 59.9m in the third quarter of 1991. Net profits for the first nine months of 1992 were Dollars 14.6m, down from Dollars 44.2m in the same period last year. Revenues were Dollars 402.3m, up from Dollars 396.4m, while R&amp;D spending was Dollars 208.9m, up from Dollars 161.6m. On Wall Street, Genentech's stock price was Dollars  1/8 higher at Dollars 33 1/4.</p>
		</main>
</body></html>
            